In 2012 the cumulative turnover of the group’s three divisions stood at RON4.44 billion.
Mediplus Exim, the leading Romanian pharmaceutical distributor, had a turnover of RON3.25 billion, up 3.4% on the year, while its net profit slumped 74%, to RON16 million.
Mediplus has a logistic network of ten regional warehouses and a national logistic center and a portfolio of more than 8,500 products and over 4,500 clients (hospitals, oped and closed circuit drugstores).
A&D Pharma’s 400-unit Sensiblu drugstore chain had a turnover of RON1.3 billion in 2013, 19% higher on the year, but posted a loss of RON38.9 million, 39% lower than in 2012, when its loss stood at RON63.5 million. In 2012, the company bought 90 City Pharma drugstores.
The turnover of the A&D Marketing&Sales division declined 9% on the year in 2013, to RON185.15 million and the company switched to a RON5.26 million loss from a profit of RON16 million in 2012. The marketing division operates in Bulgaria, Czech Republic, Poland, Romania, Serbia, Slovakia and Hungary.
A&D Pharma group is owned by businessmen Walid Abboud, Roger Akoury, Ludovic Robert and Michel Eid.
(Conversion in euros considered the average exchange rate calculated by the Romanian central bank for 2013, of RON4.419 to the euro.)